Summary Phorbol-12-myristate-13-acetate (PMA) induces p21 WAF-1 expression in human myeloid leukaemic HL-60 cells. We show that this induction is specifically mediated by protein kinase C (PKC). In addition, the PKC inhibitor Ro 31-8220 with predominant PKC-a isoform specificity almost completely inhibited PMA-induced up-regulation of p21 WAFi in HL-60 cells as well as in the myelomonocytic leukaemic U937 cells. Pretreatment of HL-60 cells with Ro 31-8220 also inhibited PMA-induced activation of c-raf-1, a known PKC a target. In the phorbol ester-tolerant HL-60 subline (PET) with PKC-P isoform deficiency PMA or bryostatin-1 induced p21 WAFI expression, but to a lesser extent than in wild-type HL-60 cells. In PET cells, Ro 31-8220 also inhibited PMA and bryostatin-1 -induced up-regulation of p21 WAFi expression. Our findings indicate that at least in HL-60 cells up-regulation of p21 WAF-1 is specifically activated by PKC. We suggest that PKC isoforms other than 1B, presumably the PKC-a isoform, are involved in this process.
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Cancer is characterized by profound alterations both in cell cycle control and in cellular differentiation. Such mechanisms can be studied with the help of cell line models, for example leukaemic cell lines in which both proliferation and differentiation programmes may be analysed. Phorbol ester-induced differentiation of human leukaemic myeloid HL-60 cells towards monocytelike cells is associated with growth arrest in the G, phase of the cell cycle. The CKI p21WAFJ (wild-type p53-activatedftagment-1) is a mediator of G1 cycle arrest induced by wild-type p53 protein (El-Deiry et al, 1993) , and in human leukaemia p21WAFI expression may be up-regulated independently from p53 (Schwaller et al, 1995; Zhang et al, 1995; Blagosklonny et al, 1996) .
Phorbol esters are potent activators of protein kinase C (PKC), a family of serine-threonine protein kinases that act as a central mediators of signal transduction pathways (Castagna, 1987) . In HL-60 cells concordant expression pattern of PKC-a and -0 isoenzymes is seen during phorbol ester-induced monocytic differentiation (Aihara et al, 1991; Edashige et al, 1992) . To examine the role of PKC in up-regulating p21WAFJ expression, we modulated p21WAFI expression by several PKC activators and inhibitors. We also investigated the expression of c-raf-1, a protein serine-threonine kinase required for p21WAFI induction and up-stream regulation of mitogenactivated protein (MAP) kinase (Blagosklonny et al, 1995 (Blagosklonny et al, 1995; Schwaller et al, 1995) .
Northern blot analysis RNA extraction and Northern blotting as well as hybridization were performed as described previously (Schwaller et al, 1995) . Human cDNA probes were: p21WAFI (2.1 kb; BamHI-HindIII) from pCEP (El-Deiry et al, 1993) , and 3-actin (0.7 kb; EcoRIBamHI, from pHF-A-3'UTR (Schwaller et al, 1995) .
Western blot analysis Total cellular protein was extracted and Western blotted as described (Schwaller et al, 1995 closely related to the tumour promoting diterpenes but displays very low affinity for PKC (Castagna, 1987) . No increase of p2lWAF) expression was seen. Thus, in HL-60 cells induction of p2lWAFJ expression by PMA is mediated by activation of PKC.
Dose-dependent inhibition of PMA-induced p21 WAFI expression by the PKC inhibitor Ro 31-8220 In contrast to commonly used PKC inhibitors, for example staurosporine, Ro 31-8220 is less potent but more selective (Wilkinson et al, 1993) . Preincubation with Ro 31-8220 (500-1000 nM) for 1 h almost completely inhibited PMA-induced p21 WAFI mRNA and protein expression (Figure 2A Bryostatin-1 induced p21 WAF1 expression is also inhibited by Ro 31-8220
Bryostatins activate PKC but lack tumour-promoting properties (Smith et al, 1985) . Continuous exposure of primary cultures of human acute leukaemia cells and various HL-60 cell clones to bryostatin-1 promotes growth arrest and terminal differentiation towards a monocyte-macrophage-like cell (Stone et al, 1988) . Treatment of our HL-60 cell clone with bryostatin-1 (0.1-1000 nM) induced peak levels of p21WAF) mRNA expression at concentrations of 1-10 nM. A rapid induction of p21 WAFI mRNA and protein expression was seen after approximately 90 min of bryostatin-1 exposure (5 nM; Figure 3A and B), but did not occur in cells preincubated for 1 h with Ro 31-8220.
p21 WAF1 expression in the phorbol ester-tolerant HL-60 subline PET by PMA and Ro Phorbol ester resistance of the PET variant of HL-60 cells is due to lack of PKC-1 expression (Macfarlane et al, 1988 (Macfarlane et al, , 1994 PMA induced c-raf-1 protein phosphorylation is inhibited by In human MCF7 breast carcinoma cells induction of p21WAFI by PMA is mediated via PKC-ax activation of c-raf-1 (Kolch et al, 1993; Blagosklonny et al, 1995) . We confirm that in HL-60 cells PMA phosphorylates c-raf-1 protein resulting in a band shift on the Western blot and show that preincubation with Ro 31-8220 almost completely inhibited PMA-induced c-raf-1 phosphorylation ( Figure 5 ).
DISCUSSION
The PKC multigene family consists of at least 11 known isoforms thought to regulate a variety of cellular activities (Blobe et al, 1994) . HL-60 cells contain PKC-a, PKC-0 and PKC-6, but not PKC-y (Aihara et al, 1991; Edashige et al, 1992) . Although many agents are known to block PKC activity, only few are highly specific and none of them exclusively inhibit a given PKCisoform. We found almost complete inhibition of PMA-induced p21WAFI up-regulation by the rather specific PKC-ax inhibitor Ro 31-8220, which indicates that this isoform might play an important role in mediating this effect (Wilkinson et al, 1993) . The PMA resistance of two PKCf-deficient HL60 sublines (PET, can be restored by either PKC-P gene transfection or 1,25-dihydroxyvitamin D3 induced up-regulation of PKC-3 (Macfarlane et al, 1994; Tonetti et al, 1994 However, as no PKC inhibitor is absolutely isoform specific, two other PKC isoforms (a, 6) are also reasonable candidates. Interestingly, in several cell lines, increase in PKC-a expression was accompanied by growth inhibition and differentiation (Kindregan et al, 1994) . PKC-a activates c-raf-1 by direct phosphorylation and c-raf-l in turn can activate the mitogen-activated protein (MAP) kinases (Kolch et al, 1993) . Two recent reports have indicated that induction of p21WAFI expression is dependent on c-raf-1 and activation of MAP kinases (Blagosklonny et al, 1995; Liu et al, 1996) . We found that in HL-60 cells the PMAinduced c-raf-1 phosphorylation can almost completely be prevented by Ro 31-8220, perhaps pointing to a role of PKCa in the induction of p21 WAF) expression in these cells.
In conclusion, our experiments show that in the HL-60 cell leukaemia model up-regulation of the p2lWAFI is mediated by PKC and PKC isoforms other than i presumably the a type are involved.
